Background illustration for clinical trials search

Paid Clinical Trials Dallas

Discover 1,917 paid clinical trials in Dallas, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Dallas TX, Houston TX, San Antonio TX, Germantown TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase1, Phase2, Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Dallas TX, Tyler TX, Austin TX, Houston TX,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Dallas TX, Bedford TX, Grapevine TX, Fort Worth TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Dallas TX, Flower Mound TX, Fort Worth TX, Tyler TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Dallas TX, Temple TX, Round Rock TX, Abilene TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Dallas TX, Flower Mound TX, Austin TX, Oklahoma City OK,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase1, Phase2, Recruiting

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

for
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy,
Location: Dallas TX, Houston TX, Nashville TN, Aurora CO,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07223203

Phase3, Recruiting

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Colorectal Cancer,
Location: Dallas TX, Tyler TX, Oklahoma City OK, Houston TX,
Sponsor: Merus B.V.

Sex: All

Age: 18+

Code: NCT03526835

Phase1, Phase2, Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: Dallas TX, Irving TX, Nashville TN, Louisville KY,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase1, Phase2, Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Dallas TX, Houston TX, Little Rock AR, Nashville TN,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase1, Recruiting

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),
Location: Dallas TX, Tyler TX, Austin TX, Houston TX,
Sponsor: Stingray Therapeutics

Sex: All

Age: 18+

Code: NCT06589440

Phase2, Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Dallas TX, Tyler TX, Temple TX, Round Rock TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase3, Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Dallas TX, Houston TX, Germantown TN, Westwood KS,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase3, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Dallas TX, Tyler TX, Austin TX, Spring TX, Houston TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Dallas TX, Austin TX, Houston TX, Laredo TX, Fairway KS,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase1, Phase2, Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Dallas TX, Nashville TN, Denver CO, Atlanta GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07226843

Phase1, Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: Dallas TX, Tyler TX, Shreveport LA, San Antonio TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase3, Recruiting

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer (SCLC)
Location: Dallas TX, Irving TX, Plano TX, Arlington TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07226999

Phase2, Phase3, Recruiting

Analysis of Graft Function Following Autologous Islet Transplantation

for
Chronic Pancreatitis
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: All

Age: 18+

Code: NCT03097185

Recruiting

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for
Breast Neoplasms, Neoplasm Metastasis
Location: Dallas TX, The Woodlands TX, Houston TX, Baytown TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07174336

Phase3, Recruiting

Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.

These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.

Why choose Dallas for clinical trials?

Dallas offers distinct advantages for those considering participation in clinical trials. The city's growing health sciences industry and diverse population provides a wide range of participants, which improves the accuracy and applicability of research findings. Dallas is also renowned for its innovative research landscape, with a strong emphasis on medical advancements and groundbreaking studies.

Common conditions studied in Dallas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Dallas